Anders D Hove Receives Stock Award at Arca biopharma Inc (ABIO) — SEC Form 4, Jan 13, 2021

SEC Form 4 · No Market Transaction

Stock Award

Compensation grant — no market purchase or sale.

Reporting Owner

Anders D Hove

Director

TXN 2021-01-12 · FILED 2021-01-13

Filing Lag 1 business day within 2-day SEC deadline

Form 4 · Statement of Changes in Beneficial Ownership

Arca biopharma Inc

ABIO CIK 0000907654

Reporting Owner

Name	Relationship
Anders D Hove CIK 0001365618	Director

Anders D Hove at Arca biopharma Inc Full insider history

Bought (12 mo) —

Sold (12 mo) —

More from this insider at Arca biopharma Inc

2024-01-31	Award	—	View
2022-12-19	Award	—	View

Derivative Securities Transactions

Title	Strike	Date	Type	Shares	Price	Expiration	Underlying	Ownership
Stock Option (right to buy)F1	$4.31	2021-01-12	A - Award/Grant	12,000 A	$0.00	2031-01-12	12,000 Common Stock	Direct

Footnotes (1)

F1: Grant to the Reporting Person of a stock option under the 2020 Equity Incentive Plan, vesting in 36 equal monthly installments beginning as of December 21, 2020. If the Reporting Person's service as a director of the Issuer terminates in connection with or at any time following a change in control (for whatever reason), then any unexpired options that remain unvested shall become fully vested. Show more

Institutional Holders

Largest by reported value

5%+ Holders · 13D/G 5 filers

Latest Schedule 13D/G per filer; stakes the filer reported closed are left out.

Other insiders at Arca biopharma Inc

GET /v1/forms/4/0001209191-21-003472 API docs